Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations
PHASE1CompletedINTERVENTIONAL
Enrollment
26
Participants
Timeline
Start Date
May 31, 2013
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Conditions
Healthy Volunteers
Interventions
DRUG
V0498 - A mg
Single oromucosal administration
DRUG
Ibuprofen
Single oral administration
Trial Locations (1)
B-4000
Liège
All Listed Sponsors
lead
Pierre Fabre Medicament
INDUSTRY
NCT01859377 - Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations | Biotech Hunter | Biotech Hunter